BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 23785468)

  • 1. Fitness costs of mutations at the HIV-1 capsid hexamerization interface.
    Manocheewa S; Swain JV; Lanxon-Cookson E; Rolland M; Mullins JI
    PLoS One; 2013; 8(6):e66065. PubMed ID: 23785468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Second-site suppressors of HIV-1 capsid mutations: restoration of intracellular activities without correction of intrinsic capsid stability defects.
    Yang R; Shi J; Byeon IJ; Ahn J; Sheehan JH; Meiler J; Gronenborn AM; Aiken C
    Retrovirology; 2012 Apr; 9():30. PubMed ID: 22515365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association equilibrium of the HIV-1 capsid protein in a crowded medium reveals that hexamerization during capsid assembly requires a functional C-domain dimerization interface.
    Bocanegra R; Alfonso C; Rodríguez-Huete A; Fuertes MÁ; Jiménez M; Rivas G; Mateu MG
    Biophys J; 2013 Feb; 104(4):884-93. PubMed ID: 23442967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Second-site compensatory mutations of HIV-1 capsid mutations.
    Noviello CM; López CS; Kukull B; McNett H; Still A; Eccles J; Sloan R; Barklis E
    J Virol; 2011 May; 85(10):4730-8. PubMed ID: 21367891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional surfaces of the human immunodeficiency virus type 1 capsid protein.
    von Schwedler UK; Stray KM; Garrus JE; Sundquist WI
    J Virol; 2003 May; 77(9):5439-50. PubMed ID: 12692245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The NTD-CTD intersubunit interface plays a critical role in assembly and stabilization of the HIV-1 capsid.
    Yufenyuy EL; Aiken C
    Retrovirology; 2013 Mar; 10():29. PubMed ID: 23497318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Site-specific structural variations accompanying tubular assembly of the HIV-1 capsid protein.
    Bayro MJ; Chen B; Yau WM; Tycko R
    J Mol Biol; 2014 Mar; 426(5):1109-27. PubMed ID: 24370930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Recent Progress and Practical Prospects for the HIV-1 Capsid Structure].
    Wang Z; Zhang J
    Bing Du Xue Bao; 2016 Sep; 32(5):634-9. PubMed ID: 30003770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Host cofactors and pharmacologic ligands share an essential interface in HIV-1 capsid that is lost upon disassembly.
    Price AJ; Jacques DA; McEwan WA; Fletcher AJ; Essig S; Chin JW; Halambage UD; Aiken C; James LC
    PLoS Pathog; 2014 Oct; 10(10):e1004459. PubMed ID: 25356722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mature HIV-1 capsid structure by cryo-electron microscopy and all-atom molecular dynamics.
    Zhao G; Perilla JR; Yufenyuy EL; Meng X; Chen B; Ning J; Ahn J; Gronenborn AM; Schulten K; Aiken C; Zhang P
    Nature; 2013 May; 497(7451):643-6. PubMed ID: 23719463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the invariable residue 51 mutations of human immunodeficiency virus type 1 capsid protein on in vitro CA assembly and infectivity.
    Abdurahman S; Youssefi M; Höglund S; Vahlne A
    Retrovirology; 2007 Sep; 4():69. PubMed ID: 17903253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 Matrix Trimerization-Impaired Mutants Are Rescued by Matrix Substitutions That Enhance Envelope Glycoprotein Incorporation.
    Tedbury PR; Novikova M; Alfadhli A; Hikichi Y; Kagiampakis I; KewalRamani VN; Barklis E; Freed EO
    J Virol; 2019 Dec; 94(1):. PubMed ID: 31619553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of HIV-1 Maturation via Small-Molecule Targeting of the Amino-Terminal Domain in the Viral Capsid Protein.
    Wang W; Zhou J; Halambage UD; Jurado KA; Jamin AV; Wang Y; Engelman AN; Aiken C
    J Virol; 2017 May; 91(9):. PubMed ID: 28202766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rhesus monkey TRIM5α SPRY domain recognizes multiple epitopes that span several capsid monomers on the surface of the HIV-1 mature viral core.
    Biris N; Tomashevski A; Bhattacharya A; Diaz-Griffero F; Ivanov DN
    J Mol Biol; 2013 Dec; 425(24):5032-44. PubMed ID: 23886867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation in the loop C-terminal to the cyclophilin A binding site of HIV-1 capsid protein disrupts proper virus assembly and infectivity.
    Abdurahman S; Höglund S; Höglund A; Vahlne A
    Retrovirology; 2007 Mar; 4():19. PubMed ID: 17371591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Residues in the HIV-1 capsid assembly inhibitor binding site are essential for maintaining the assembly-competent quaternary structure of the capsid protein.
    Bartonova V; Igonet S; Sticht J; Glass B; Habermann A; Vaney MC; Sehr P; Lewis J; Rey FA; Kraüsslich HG
    J Biol Chem; 2008 Nov; 283(46):32024-33. PubMed ID: 18772135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal structure of an antiviral ankyrin targeting the HIV-1 capsid and molecular modeling of the ankyrin-capsid complex.
    Praditwongwan W; Chuankhayan P; Saoin S; Wisitponchai T; Lee VS; Nangola S; Hong SS; Minard P; Boulanger P; Chen CJ; Tayapiwatana C
    J Comput Aided Mol Des; 2014 Aug; 28(8):869-84. PubMed ID: 24997121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Motions on the millisecond time scale and multiple conformations of HIV-1 capsid protein: implications for structural polymorphism of CA assemblies.
    Byeon IJ; Hou G; Han Y; Suiter CL; Ahn J; Jung J; Byeon CH; Gronenborn AM; Polenova T
    J Am Chem Soc; 2012 Apr; 134(14):6455-66. PubMed ID: 22428579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lethal mutations in the major homology region and their suppressors act by modulating the dimerization of the rous sarcoma virus capsid protein C-terminal domain.
    Dalessio PM; Craven RC; Lokhandwala PM; Ropson IJ
    Proteins; 2013 Feb; 81(2):316-25. PubMed ID: 23011855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allosteric Regulation of HIV-1 Capsid Structure for Gag Assembly, Virion Production, and Viral Infectivity by a Disordered Interdomain Linker.
    Koma T; Kotani O; Miyakawa K; Ryo A; Yokoyama M; Doi N; Adachi A; Sato H; Nomaguchi M
    J Virol; 2019 Sep; 93(17):. PubMed ID: 31189701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.